Every SEC filing alert our engine sent, newest first: 8-K material events, deals, capital raises, leadership changes, results and insider buying and selling.
Genius Sports Chief Commercial Officer Jack Davison Sells $184K of Stock
Jack Davison, Chief Commercial Officer, sold 30,000 shares of Genius Sports Ltd at $6.14 a share, worth $184K in total on Nov 12, 2026. Shares held after the trade: 1,999,706 (-1.5%).
Evernorth Holdings Inc. reported its third-quarter 2026 financial results, highlighting continued growth in its pharmacy benefit management and specialty pharmacy segments. The filing indicates a focus on expanding specialty pharmacy capabilities and managing medical cost trends effectively while maintaining stable full-year guidance.
Boston Omaha Corporation's Board of Directors has voted to significantly increase its share repurchase program from $30 million to $85 million. The program allows for repurchases of Class A common stock through open market or private transactions and is set to expire on December 31, 2027. The company intends to fund the buybacks using available cash and cash equivalents.
For the quarter ended September 30, 2026, eGain reported total revenue of $21.9 million, a decrease from $23.5 million in the prior year, primarily driven by lower SaaS and professional services revenue. Net income declined to $1.55 million ($0.06 per diluted share) compared to $2.82 million ($0.10 per diluted share) in the same period last year. The company continued its share repurchase program, spending $3.6 million to buy back 644,000 shares during the quarter.
NIQ Global Intelligence reported Q3 2026 financial results, achieving positive GAAP EPS for the first time since its IPO with net income of $35.8 million. The company exceeded guidance across all key metrics, raised its full-year 2026 outlook, and announced a new $150 million share repurchase authorization after reaching its net leverage target ahead of schedule.
“Q3 was a milestone quarter — we exceeded the top end of our guidance across all key metrics for the sixth consecutive quarter, delivered positive GAAP earnings per share for the first time since our IPO, and reached our net leverage milestone a quarter ahead of plan.”
Jim Peck, Executive Chairman and Chief Executive Officer
Core University Living Real Estate Income Trust commenced operations in July 2026, acquiring an initial portfolio of four student housing properties for approximately $300.5 million. For the period from formation through September 30, 2026, the company reported a net loss of $2.8 million on rental revenues of $6.3 million, primarily due to depreciation, interest expense, and general and administrative costs.
PharmaCyte Biotech implemented a 1-for-19 reverse stock split of its common stock effective November 12, 2026. The split consolidated approximately 10.8 million outstanding shares into roughly 0.57 million shares to increase the per-share trading price. The action is intended to help the company regain compliance with the Nasdaq minimum bid price requirement for continued listing.
As of September 30, 2026, the Hashdex Nasdaq CME Crypto Index ETF reported net assets of $498.3 million, a significant increase from $121.3 million at the end of 2025. The Trust's portfolio is heavily weighted in Bitcoin (73.79%) and Ethereum (11.98%), and it recently transitioned its reference index to the Nasdaq CME Crypto Settlement Price Index in January 2026.
Icu Medical Insider Elisha W. Finney Sells $316K of Stock
Elisha W. Finney sold 1,765 shares of Icu Medical Inc at $179.00 a share, worth $316K in total between Nov 12, 2026 and Nov 13, 2026. Shares held after the trade: 4,871 (-25.9%).
Arxis Insider Ross Bradley Sealfon Sells $783K of Stock
Ross Bradley Sealfon sold 15,000 shares of Arxis, Inc. at $51.44 to $53.03 a share (average $52.23) in 3 transactions, worth $783K in total on Nov 11, 2026. Shares held after the trade: 1,087,807 (-0.4%).
Altimmune CFO Gregory L. Weaver Buys $16.2K of Stock
Gregory L. Weaver, CFO, bought 10,000 shares of Altimmune, Inc. at $1.62 a share, worth $16.2K in total on Nov 13, 2026. Shares held after the trade: 73,005 (+15.9%).
Cavco Industries President,Manufactured Housing Brian R. Cira Sells $1.59M of Stock
Brian R. Cira, President,Manufactured Housing, sold 2,382 shares of Cavco Industries, Inc. at $666.91 a share, worth $1.59M in total on Nov 10, 2026. Shares held after the trade: 1,908 (-55.5%).
Altimmune Director Wayne Pisano Buys $16.4K of Stock
Wayne Pisano, Director, bought 10,000 shares of Altimmune, Inc. at $1.64 a share, worth $16.4K in total on Nov 13, 2026. Shares held after the trade: 58,800 (+20.5%).
Aldeyra Therapeutics Director Richard Douglas Buys $129K of Stock
Richard Douglas, Director, bought 200,000 shares of Aldeyra Therapeutics, Inc. at $0.6445 a share, worth $129K in total on Nov 11, 2026. Shares held after the trade: 395,000 (+102.6%).
Cinemark Holdings, Inc. declared a quarterly cash dividend of $0.09 per share of common stock. The dividend is scheduled to be paid on December 9, 2026, to stockholders of record as of November 25, 2026.
Ares Industrial Real Estate Income Trust Business Update
Ares Industrial Real Estate Income Trust reported its monthly Net Asset Value (NAV) as of October 31, 2026, with an Aggregate Fund NAV of approximately $5.31 billion. The transaction price for December 1, 2026, will be based on this updated NAV per share calculation. The filing also details the company's total investment portfolio of $10.36 billion, which includes industrial properties, joint ventures, and real estate debt.
Altimmune President and CEO Jerome Benedict Durso Buys $49.7K of Stock
Jerome Benedict Durso, President and CEO, bought 30,700 shares of Altimmune, Inc. at $1.62 a share, worth $49.7K in total on Nov 13, 2026. Shares held after the trade: 93,200 (+49.1%).
Vine Hill Capital Investment Corp. II reported net income of $4.97 million for the nine months ended September 30, 2026, primarily driven by $6.25 million in interest income from its Trust Account. As a shell company, it continues to seek an initial business combination while maintaining $236.5 million in Class A ordinary shares subject to possible redemption.
Darren S. Raiguel, COO, sold 4,268 shares of Eplus Inc at $98.12 to $99.26 a share (average $98.26) in 3 transactions, worth $419K in total between Nov 11, 2026 and Nov 12, 2026. Shares held after the trade: 60,768 (-0.5%).
Enbridge $1.1B Debt Financing with Deutsche Bank Trust Company Americas
Enbridge Inc. completed a dual-tranche debt offering totaling $1.1 billion in aggregate principal amount. The offering consisted of $550 million in 6.700% Series A Fixed-to-Fixed Rate Subordinated Notes and $550 million in 6.875% Series B Fixed-to-Fixed Rate Subordinated Notes, both due in 2057.
Ares Real Estate Income Trust Inc. reported its monthly Net Asset Value (NAV) update for October 31, 2026, showing an Aggregate Fund NAV of approximately $3.95 billion. The company's total real estate investment portfolio was valued at $9.30 billion, with industrial and residential properties representing the largest asset classes. The transaction price for share classes starting December 1, 2026, will be based on these October 31 NAV calculations.
FiEE, Inc. reported a significant turnaround for the nine months ended September 30, 2026, achieving net income of $3.58 million compared to a net loss of $1.27 million in the prior year period. This growth was driven by a substantial increase in revenues to $9.57 million, up from $1.98 million, alongside the acquisition of new subsidiaries.
Suncrete, Inc. filed an amendment to its Q3 2026 earnings report to correct errors in its full-year 2026 outlook caused by a technical disruption. The company updated its projected net loss to a range of $43.7M to $39.7M and its adjusted net loss to $16.8M to $12.8M, while maintaining its previously issued revenue and Adjusted EBITDA guidance.
Kontoor Brands announced that Jennifer H. Broyles will transition to the role of Executive Vice President, Global Brand President, Wrangler. This title change is effective upon the closing of the company's previously announced sale of its Lee business. Ms. Broyles will continue to serve as an executive officer of the company.
Genpact SVP and CHRO Piyush Mehta Sells $8.61M of Stock
Piyush Mehta, SVP and CHRO, sold 200,000 shares of Genpact LTD at $43.05 a share, worth $8.61M in total on Nov 10, 2026. Shares held after the trade: 156,823 (-56.1%).
Goldman Sachs filed Certificates of Elimination to its Restated Certificate of Incorporation to remove all designations related to its Series O and Series V Preferred Stock. This administrative action follows the full redemption of all outstanding shares of both series on November 10, 2026.
Next Bridge Hydrocarbons, Inc. reported 288,458,813 shares of common stock outstanding as of November 13, 2026. The filing indicates the company is classified as a non-accelerated filer, a smaller reporting company, and an emerging growth company, with financial statements covering the quarter ended September 30, 2026.
Annovis Bio reported third quarter 2026 financial results and provided a clinical update on its Phase 3 DUET-AD study for Alzheimer's disease, with a data readout expected in March 2027. The company also highlighted a $21.0 million capital raise from an underwritten public offering intended to fund operations through the upcoming clinical milestones.
Term
Q3 2026
“The third quarter marked a shift in our focus from enrolling patients in DUET-AD to executing the trial and preparing for the first data readout and for filing a New Drug Application (NDA). We now have dates set for last patient, last visit of the 6-month treatment period and for database lock, as well as financing in place to carry us through topline results in March 2027. The team is working very hard to deliver clean data and an on-time readout.”
Maria Maccecchini, PhD, President and CEO of Annovis
Invesco Commercial Real Estate Finance Trust Business Update
Invesco Commercial Real Estate Finance Trust, Inc. reported its monthly Net Asset Value (NAV) as of October 31, 2026, totaling approximately $1.5 billion. The NAV per share across its various share classes ranged from $24.87 to $26.27, which will serve as the transaction price for December 1, 2026. The company's portfolio is primarily composed of $6.99 billion in commercial real estate loan investments offset by $5.74 billion in financing liabilities.
Bowhead Specialty Holdings M&A Deal with American Family Mutual Insurance Company, S.I.
Bowhead Specialty Holdings stockholders approved the company's acquisition by American Family Mutual Insurance Company, S.I. at a special meeting held on November 13, 2026. Additionally, CFO and Treasurer Brad Mulcahey announced his intention to depart the company in April 2027, though his departure is not due to any disagreements with the company.